[	O
H	O
.	O
pylori	O
infection	O
.	O
Our	O
experience	O
with	O
the	O
quadruple	O
and	O
triple	O
therapy	O
as	O
first	O
pharmacologic	O
approach	O
]	O
.	O

For	O
now	O
the	O
most	O
used	O
pharmacological	O
treatment	O
of	O
first	O
instance	O
to	O
eradication	O
of	O
Hp	O
foresees	O
utilization	O
of	O
triple	O
therapy	O
(	O
PPI	O
+	O
two	O
antibiotics	O
)	O
.	O

In	O
our	O
study	O
we	O
have	O
compared	O
this	O
kind	O
of	O
treatment	O
with	O
the	O
quadruple	O
therapy	O
(	O
PPI	O
+	O
three	O
antibiotics	O
)	O
,	O
that	O
have	O
showed	O
a	O
taller	O
percentage	O
of	O
eradication	O
at	O
the	O
end	O
of	O
first	O
therapeutical	O
cycle	O
with	O
a	O
shorter	O
time	O
and	O
lower	O
price	O
of	O
treatment	O
.	O

